On November 29, 2022, Organicellâs Board of Directors (âBoardâ) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Companyâs Board of Directors. The Board also agreed to appoint Mr. Ian Bothwell, the Companyâs Chief Financial Officer to serve as the Companyâs Interim Chief Executive Officer while the Board commences its process to identify suitable candidates to fill the Chief Executive Officer position.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +7.69% | 0.00% | +9.80% |
18/03 | Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
05/03 | Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.80% | 68.61L | |
+19.88% | 7.17TCr | |
-2.43% | 2.37TCr | |
+9.05% | 900.94Cr | |
+10.34% | 864.08Cr | |
-19.68% | 814.74Cr | |
+13.68% | 533.31Cr | |
+14.69% | 435.48Cr | |
-1.04% | 409.63Cr | |
-2.27% | 394.49Cr |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Announces Management Changes